ICUAWMyokinE100 System for ICU Acquired Weakness Prevention

This clinical trial focuses on testing the safety and usability of a new medical device, the MyokinE100 System, in the Intensive Care Unit (ICU). The device is designed to send electrical signals to the thigh muscles of ICU patients who are at risk of losing muscle strength. The study's main aim is to explore whether this treatment can help slow down muscle weakening, a common issue among critically ill patients. The trial is important as it could potentially improve patient care and recovery in the ICU by addressing the challenge of muscle weakness. During the study, participants will either receive standard care or standard care along with daily 60-minute sessions of electrical muscle stimulation using the MyokinE100 System. Researchers will compare these two groups to evaluate the safety and practicality of the device. Participants' muscle strength will be checked throughout the study. Additionally, they will complete a survey three months after leaving the ICU to assess their recovery progress. The study will investigate if participants experience any medical problems while receiving electrical muscle stimulation in the ICU.